Bill

Bill > HR8855


US HR8855

US HR8855
Sickle Cell Disease Treatment Centers Act of 2022


summary

Introduced
09/15/2022
In Committee
09/16/2022
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To establish a program to address sickle cell disease and other heritable hemoglobinopathies.

AI Summary

This bill establishes a program to address sickle cell disease and other heritable hemoglobinopathies. It creates "Sickle Cell Disease Treatment Centers" that use a hub-and-spoke framework to promote access to coordinated healthcare, provide support for integrated care teams, improve patient health and well-being, increase reporting on quality measures, and conduct public health activities. The bill defines key terms like "community-based organization," "eligible entity," and "hub-and-spoke network." It outlines how grant funds can be used by medical hubs, community-based organizations, and spokes. The bill also establishes a National Sickle Cell Disease Coordinating Center to coordinate the activities of the Treatment Centers and a data collection program at the Centers for Disease Control and Prevention. The bill authorizes $535 million annually to carry out these provisions.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (5)

Last Action

Referred to the Subcommittee on Health. (on 09/16/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...